{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:21:21Z","timestamp":1790230881568,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Research Grant Council, Hong Kong Government"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.bcp.2009.10.021","type":"journal-article","created":{"date-parts":[[2009,10,31]],"date-time":"2009-10-31T08:24:56Z","timestamp":1256977496000},"page":"842-852","source":"Crossref","is-referenced-by-count":19,"title":["Reverse phase protein array identifies novel anti-invasion mechanisms of YC-1"],"prefix":"10.1016","volume":"79","author":[{"given":"Bo","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian W.Y.","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin P.","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiling","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horasis S.Y.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine Y.L.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk-Hang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret H.L.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon B.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony T.C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2009.10.021_bib1","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/annonc\/mdf179","article-title":"Nasopharyngeal carcinoma","volume":"13","author":"Chan","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bcp.2009.10.021_bib2","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/S0959-8049(03)00367-8","article-title":"Nasopharyngeal carcinomas: an update","volume":"39","author":"Spano","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bcp.2009.10.021_bib3","series-title":"Cancer epidemiology and prevention","first-page":"721","article-title":"Cancer of the pancreas","author":"Anderson","year":"2006"},{"key":"10.1016\/j.bcp.2009.10.021_bib4","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1177\/000348949110000705","article-title":"Nasopharyngeal carcinoma: modes of presentation","volume":"100","author":"Skinner","year":"1991","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.bcp.2009.10.021_bib5","first-page":"1183","article-title":"Advanced nasopharyngeal carcinoma treated with chemotherapy and radiotherapy: distant metastasis and local recurrence","volume":"12","author":"Isobe","year":"1998","journal-title":"Int J Oncol"},{"key":"10.1016\/j.bcp.2009.10.021_bib6","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1182\/blood.V84.12.4226.bloodjournal84124226","article-title":"YC-1, a novel activator of platelet guanylate cyclase","volume":"84","author":"Ko","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2009.10.021_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.canlet.2007.03.026","article-title":"Preclinical evaluation of YC-1, a HIF inhibitor, for the prevention of tumor spreading","volume":"255","author":"Shin","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bcp.2009.10.021_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1124\/jpet.105.085126","article-title":"YC-1 [3-(5\u2032-hydroxymethyl-2\u03b3-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models","volume":"314","author":"Pan","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2009.10.021_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2004.01.005","article-title":"Versatile pharmacological actions of YC-1: anti-platelet to anticancer","volume":"207","author":"Chun","year":"2004","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bcp.2009.10.021_bib10","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1002\/pmic.200700200","article-title":"Proteomic approach to studying the cytotoxicity of YC-1 on U937 leukemia cells and antileukemia activity in orthotopic model of leukemia mice","volume":"7","author":"Chung","year":"2007","journal-title":"Proteomics"},{"key":"10.1016\/j.bcp.2009.10.021_bib11","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1158\/1535-7163.MCT-05-0090","article-title":"YC-1 suppresses constitutive nuclear factor-kappaB activation and induces apoptosis in human prostate cancer cells","volume":"4","author":"Huang","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2009.10.021_bib12","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/jnci\/95.7.516","article-title":"YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1","volume":"95","author":"Yeo","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bcp.2009.10.021_bib13","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.4161\/cbt.6.12.4970","article-title":"Inhibition of Stat3 activity by YC-1 enhances chemo-sensitivity in hepatocellular carcinoma","volume":"6","author":"Lau","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.bcp.2009.10.021_bib14","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.bcp.2007.08.011","article-title":"Anticancer mechanisms of YC-1 in human lung cancer cell line, NCI-H226","volume":"75","author":"Chen","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2009.10.021_bib15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/bjp.2008.292","article-title":"YC-1 induces apoptosis of human renal carcinoma A498 cells in vitro and in vivo through activation of the JNK pathway","volume":"155","author":"Wu","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2009.10.021_bib16","doi-asserted-by":"crossref","first-page":"6345","DOI":"10.1158\/0008-5472.CAN-05-4460","article-title":"YC-1 induces S cell cycle arrest and apoptosis by activating checkpoint kinases","volume":"66","author":"Yeo","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2009.10.021_bib17","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1158\/1535-7163.MCT-06-0334","article-title":"Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells","volume":"5","author":"Tibes","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2009.10.021_bib18","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1074\/mcp.T500003-MCP200","article-title":"Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma","volume":"4","author":"Sheehan","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.bcp.2009.10.021_bib19","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1002\/pmic.200700951","article-title":"Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: accurate detection of CA19-9 levels in pancreatic cancer","volume":"8","author":"Grote","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.bcp.2009.10.021_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/bfgp\/1.3.305","article-title":"Utility of reverse phase protein arrays: applications to signalling pathways and human body arrays","volume":"1","author":"Charboneau","year":"2002","journal-title":"Brief Funct Genomic Proteomic"},{"key":"10.1016\/j.bcp.2009.10.021_bib21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1158\/1940-6207.CAPR-08-0184","article-title":"A novel derivative of the natural agent deguelin for cancer chemoprevention and therapy","volume":"1","author":"Kim","year":"2008","journal-title":"Cancer Prev Res (Phila PA)"},{"key":"10.1016\/j.bcp.2009.10.021_bib22","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1158\/1535-7163.MCT-06-0678","article-title":"Antitumor mechanisms of combined gastrin-releasing peptide receptor and epidermal growth factor receptor targeting in head and neck cancer","volume":"6","author":"Zhang","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2009.10.021_bib23","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/ijc.24567","article-title":"STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro","volume":"125","author":"Lui","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2009.10.021_bib24","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1124\/mol.106.032284","article-title":"Antiproliferative mechanisms of a transcription factor decoy targeting signal transducer and activator of transcription (STAT) 3: the role of STAT1","volume":"71","author":"Lui","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bcp.2009.10.021_bib25","unstructured":"Wong JH, Lui VW, Umezawa K, Ho Y, Wong EY, Ng MH, et al. A small molecule inhibitor of NF-kappaB, dehydroxymethylepoxyquinomicin (DHMEQ), suppresses growth and invasion of nasopharyngeal carcinoma (NPC) cells. Cancer Lett; in press."},{"key":"10.1016\/j.bcp.2009.10.021_bib26","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1038\/sj.onc.1206720","article-title":"Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor","volume":"22","author":"Lui","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2009.10.021_bib27","doi-asserted-by":"crossref","first-page":"9524","DOI":"10.1073\/pnas.86.23.9524","article-title":"Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas","volume":"86","author":"Glaser","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2009.10.021_bib28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ijc.2910310509","article-title":"Cytogenetic studies on an epithelial cell line derived from poorly differentiated nasopharyngeal carcinoma","volume":"31","author":"Sizhong","year":"1983","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2009.10.021_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev.biochem.73.011303.073723","article-title":"Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints","volume":"73","author":"Sancar","year":"2004","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.bcp.2009.10.021_bib30","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/nrm1493","article-title":"Checking on DNA damage in S phase","volume":"5","author":"Bartek","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bcp.2009.10.021_bib31","doi-asserted-by":"crossref","first-page":"14229","DOI":"10.1073\/pnas.2331323100","article-title":"Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays","volume":"100","author":"Nishizuka","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2009.10.021_bib32","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/sj.bjp.0704777","article-title":"YC-1 increases cyclo-oxygenase-2 expression through protein kinase G- and p44\/42 mitogen-activated protein kinase-dependent pathways in A549 cells","volume":"136","author":"Chang","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2009.10.021_bib33","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1200\/JCO.2005.04.8306","article-title":"Epidermal growth factor receptor biology in head and neck cancer","volume":"24","author":"Kalyankrishna","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bcp.2009.10.021_bib34","first-page":"87","article-title":"Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy","volume":"1786","author":"Iiizumi","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bcp.2009.10.021_bib35","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1023\/A:1023772912750","article-title":"Src family kinases in tumor progression and metastasis","volume":"22","author":"Summy","year":"2003","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.bcp.2009.10.021_bib36","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1517\/14728222.10.5.709","article-title":"Is caveolin-1 a viable therapeutic target to reduce cancer metastasis?","volume":"10","author":"van Golen","year":"2006","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.bcp.2009.10.021_bib37","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/hed.10307","article-title":"Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma\u2014a prospective study","volume":"25","author":"Ma","year":"2003","journal-title":"Head Neck"},{"key":"10.1016\/j.bcp.2009.10.021_bib38","first-page":"1232","article-title":"Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma","volume":"117","author":"Li","year":"2004","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.bcp.2009.10.021_bib39","doi-asserted-by":"crossref","DOI":"10.1007\/s12253-008-9144-7","article-title":"Overexpression of caveolin-1 in hepatocellular carcinoma with metastasis and worse prognosis: correlation with vascular endothelial growth factor, microvessel density and unpaired artery","author":"Zhang","year":"2009","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.bcp.2009.10.021_bib40","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/cncr.10329","article-title":"Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage","volume":"94","author":"Kato","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2009.10.021_bib41","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/sj.bjc.6604243","article-title":"Combined expression of caveolin-1 and an activated AKT\/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma","volume":"98","author":"Campbell","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2009.10.021_bib42","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1023\/A:1006110326366","article-title":"Metastasis-related genes in prostate cancer: the role of caveolin-1","volume":"17","author":"Thompson","year":"1998","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.bcp.2009.10.021_bib43","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/ijc.24531","article-title":"Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients","volume":"125","author":"Du","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bcp.2009.10.021_bib44","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0006-2952(03)00244-2","article-title":"YC-1 inhibits proliferation of human vascular endothelial cells through a cyclic GMP-independent pathway","volume":"66","author":"Hsu","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2009.10.021_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2005.04.046","article-title":"YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor","volume":"517","author":"Chiang","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2009.10.021_bib46","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0165-4608(02)00657-X","article-title":"Molecular cytogenetic characterization of nasopharyngeal carcinoma cell lines and xenografts by comparative genomic hybridization and spectral karyotyping","volume":"140","author":"Wong","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.bcp.2009.10.021_bib47","unstructured":"Ma BB, Lui VW, Poon FF, Wong SC, To KF, Wong E, et al. Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response. Invest New Drugs; in press."},{"key":"10.1016\/j.bcp.2009.10.021_bib48","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1128\/JVI.69.7.4390-4398.1995","article-title":"The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor","volume":"69","author":"Miller","year":"1995","journal-title":"J Virol"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295209009368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295209009368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T10:38:34Z","timestamp":1590230314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295209009368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0006295209009368"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2009.10.021","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}